Form D/A

View Original Filing

Notice of Exempt Offering of Securities

Item 1. Issuer's Identity

Name of Issuer:
AMGEN INC
Jurisdiction of Incorporation/Organization
DE
Year of Incorporation/Organization
Over Five Years Ago

Previous Name(s)

  • AMGEN
Entity Type
CORPORATION

Item 2 Issuer Principal Place of Business and Contact Information

ONE AMGEN CENTER DRIVE
THOUSAND OAKS, CA 91320
Phone Number: subscription required

Item 3. Related Persons

Name
KEVIN W SHARER
Address
subscription required
Relationship(s)
  • EXECUTIVE OFFICER
  • DIRECTOR
Clarification of Response

Item 3. Related Persons

Name
ROBERT A BRADWAY
Address
subscription required
Relationship(s)
  • EXECUTIVE OFFICER
  • DIRECTOR
Clarification of Response

Item 3. Related Persons

Name
DAVID W BEIER
Address
subscription required
Relationship(s)
  • EXECUTIVE OFFICER
Clarification of Response

Item 3. Related Persons

Name
FABRIZIO BONANNI
Address
subscription required
Relationship(s)
  • EXECUTIVE OFFICER
Clarification of Response

Item 3. Related Persons

Name
SEAN E. HARPER
Address
subscription required
Relationship(s)
  • EXECUTIVE OFFICER
Clarification of Response

Item 3. Related Persons

Name
ANTHONY C. HOOPER
Address
subscription required
Relationship(s)
  • EXECUTIVE OFFICER
Clarification of Response

Item 3. Related Persons

Name
BRIAN M MCNAMEE
Address
subscription required
Relationship(s)
  • EXECUTIVE OFFICER
Clarification of Response

Item 3. Related Persons

Name
JONATHAN M PEACOCK
Address
subscription required
Relationship(s)
  • EXECUTIVE OFFICER
Clarification of Response

Item 3. Related Persons

Name
ANNA S RICHO
Address
subscription required
Relationship(s)
  • EXECUTIVE OFFICER
Clarification of Response

Item 3. Related Persons

Name
DAVID J SCOTT
Address
subscription required
Relationship(s)
  • EXECUTIVE OFFICER
Clarification of Response

Item 3. Related Persons

Name
THOMAS DITTRICH
Address
subscription required
Relationship(s)
  • EXECUTIVE OFFICER
Clarification of Response

Item 3. Related Persons

Name
DAVID BALTIMORE
Address
subscription required
Relationship(s)
  • DIRECTOR
Clarification of Response

Item 3. Related Persons

Name
FRANK J BIONDI, JR.
Address
subscription required
Relationship(s)
  • DIRECTOR
Clarification of Response

Item 3. Related Persons

Name
VANCE D COFFMAN
Address
subscription required
Relationship(s)
  • DIRECTOR
Clarification of Response

Item 3. Related Persons

Name
FRANCOIS DE CARBONNEL
Address
subscription required
Relationship(s)
  • DIRECTOR
Clarification of Response

Item 3. Related Persons

Name
REBECCA HENDERSON
Address
subscription required
Relationship(s)
  • DIRECTOR
Clarification of Response

Item 3. Related Persons

Name
FRANK C HERRINGER
Address
subscription required
Relationship(s)
  • DIRECTOR
Clarification of Response

Item 3. Related Persons

Name
GILBERT S OMENN
Address
subscription required
Relationship(s)
  • DIRECTOR
Clarification of Response

Item 3. Related Persons

Name
JUDITH C PELHAM
Address
subscription required
Relationship(s)
  • DIRECTOR
Clarification of Response

Item 3. Related Persons

Name
J PAUL REASON
Address
subscription required
Relationship(s)
  • DIRECTOR
Clarification of Response

Item 3. Related Persons

Name
LEONARD D SCHAEFFER
Address
subscription required
Relationship(s)
  • DIRECTOR
Clarification of Response

Item 3. Related Persons

Name
RONALD D SUGAR
Address
subscription required
Relationship(s)
  • DIRECTOR
Clarification of Response

Item 4. Industry Group

BIOTECHNOLOGY

Item 5. Issuer Size

Revenue Range (for issuer not specifying "hedge" or "other investment" fund in Item 4 above)
DECLINE TO DISCLOSE

Item 6. Federal Exemptions and Exclusions Claimed

Item 7. Type of Filing

Amendment
Date of First Sale in this Offering:
09/28/2011

Item 8. Duration of Offering

Does the issuer intend this offering to last more than one year?
Yes

Item 9. Type(s) of Securities Offered

  • Other: COMMERCIAL PAPER

Item 10. Business Combination Transaction

Is this offering being made in connection with a business combination transaction, such as a merger, acquisition or exchange offer?
No
Clarification of Response

Item 11. Minimum Investment

Minimum Investment accepted from any outside investor
250000

Item 12. Sales Compensation

Recipient
GOLDMAN, SACHS CO.
Recipient CRD Number
361
(Associated) Broker or Dealer)
NONE
(Associated) Broker or Dealer CRD Number
NONE
Address
200 WEST STREET
NEW YORK, NY 10282
States of Solicitation
  • ALL STATES

Item 12. Sales Compensation

Recipient
BARCLAYS CAPITAL INC
Recipient CRD Number
19714
(Associated) Broker or Dealer)
NONE
(Associated) Broker or Dealer CRD Number
NONE
Address
745 7TH AVENUE
NEW YORK, NY 10019
States of Solicitation
  • ALL STATES

Item 12. Sales Compensation

Recipient
CITIGROUP GLOBAL MARKETS INC.
Recipient CRD Number
7059
(Associated) Broker or Dealer)
NONE
(Associated) Broker or Dealer CRD Number
NONE
Address
388 GREENWICH STREET
NEW YORK, NY 10013
States of Solicitation
  • ALL STATES

Item 12. Sales Compensation

Recipient
BANC OF AMERICA SECURITIES LLC
Recipient CRD Number
26091
(Associated) Broker or Dealer)
NONE
(Associated) Broker or Dealer CRD Number
NONE
Address
ONE BRYANT PARK
NEW YORK, NY 10036
States of Solicitation
  • ALL STATES

Item 12. Sales Compensation

Recipient
MORGAN STANLEY CO. INCORPORATED
Recipient CRD Number
8209
(Associated) Broker or Dealer)
NONE
(Associated) Broker or Dealer CRD Number
NONE
Address
1585 BROADWAY
NEW YORK, NY 10036
States of Solicitation
  • ALL STATES

Item 12. Sales Compensation

Recipient
DEUTSCHE BANK SECURITIES INC.
Recipient CRD Number
2525
(Associated) Broker or Dealer)
NONE
(Associated) Broker or Dealer CRD Number
NONE
Address
60 WALL STREET
NEW YORK, NY 10005
States of Solicitation
  • ALL STATES

Item 13. Offering and Sales Amounts

Total Offering Amount
2500000000
Total Amount Sold
0
Total Remaining to be Sold
2500000000
Clarification of Response
THIS IS A CONTINUOUS COMMERCIAL PAPER PROGRAM. THE TOTAL AMOUNT OFFERED REPRESENTS THE MAXIMUM AUTHORIZED AMOUNT. AS OF THE DATE OF THIS FILING, NO AMOUNTS ARE OUTSTANDING UNDER THIS PROGRAM.

Item 14. Investors

Securities in the offering have been or may be sold to persons who do not qualify as accredited investors,
Number of non-accredited investors who already have invested in the offering:
Total number of investors who already have invested in the offering:
34

Item 15. Sales Commissions and Finders' Fees Expenses

Sales Commissions:
750000.0 Is an estimate
Finders' Fees
0.0
Clarification of Response
ANNUALIZED ESTIMATE BASED ON THE TOTAL OFFERING AMOUNT OF THE PROGRAM.

Item 16. Use of Proceeds

Provide the amount of the gross proceeds of the offering that has been or is proposed to be used for payments to any of the persons required to be named as executive officers,directors or promoters in response to Item 3 above.
0.0
Clarification of Response

Signature and Submission

Notice has been signed on behalf by the undersigned duly authorized person
Issuer Name
AMGEN INC
Issuer Signature
/S/ DAVID J.SCOTT
Signer Name
DAVID J.SCOTT
Signer Title
SENIOR VICE PRESIDENT, GENERAL COUNSEL AND SECRETARY
Signature Date
02/29/2012
WhaleWisdom Logo

Elevate your investments